TorabiJCampbellANairGPatelGLMiuraYGrahamJA. Dapsone-induced methemoglobinemia in two renal transplant recipients. Prog Transplant. 2019;29(3):289–290. doi:10.1177/1526924819855365.
2.
MitsidesNGreenDMiddletonR, et al.Dapsone-induced methemoglobinemia in renal transplant recipients: more prevalent than previously thought. Transpl Infect Dis. 2014;16(1):37–43. doi:10.1111/tid.12161.
3.
EsbenshadeAJHoRHShintaniAZhaoZSmithLAFriedmanDL. Dapsone-induced methemoglobinemia: a dose-related occurrence?Cancer. 2011;117(15):3485–3492. doi:10.1002/cncr.25904.
4.
PlotkinJSBuellJFNjokuMJ, et al.Methemoglobinemia associated with dapsone treatment in solid organ transplant recipients: a two-case report and review. Liver Transpl Surg. 1997;3(2):149–152.